Chinnampalli, K. V. (2026). FROM RISK TO QUALITY: QUALITY RISK MANAGEMENT IN PHARMA TARGETING CANCER THROUGH IMMUNE MODULATION . Biospecia, 2(2), 13–17. Retrieved from https://uniquepubinternational.com/journals/index.php/biospecia/article/view/211